Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In a controlled clinical setting (STEP 1 trial), participants with obesity who were prescribed semaglutide in combination with a structured lifestyle program lost an average of 14.9% of their body weight over 68 weeks
First, retreatment efficacy has not been evaluated in clinical trials, and no relevant published literature is currently available
Their willingness to cover and pay for GLP-1s for current conditions hint at what we can expect for SUD
Is it covered by insurance
US$ 23.04
US$ 28.29
US$ 22.32
US$ 27.95
